Literature DB >> 638661

Haemodialysis during cyclophosphamide treatment.

M R Bending, R E Finch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 638661      PMCID： PMC1604289          DOI： 10.1136/bmj.1.6120.1145-d

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  [ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO].

Authors:  N BROCK; H J HOHORST
Journal:  Arzneimittelforschung       Date:  1963-12

2.  Clinical pharmacology of cyclophosphamide.

Authors:  C M Bagley; F W Bostick; V T DeVita
Journal:  Cancer Res       Date:  1973-02       Impact factor: 12.701

3.  Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite.

Authors:  D L Hill; W R Laster; R F Struck
Journal:  Cancer Res       Date:  1972-04       Impact factor: 12.701
  3 in total
  2 in total

Review 1.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  L B Grochow; M Colvin
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

Review 2.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.